Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Compound 7p shows strong potential as an anticancer agent.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Cepharanthine shows promise as a COVID-19 treatment.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Baricitinib was effective in treating both early and late onset alopecia areata.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.